147 related articles for article (PubMed ID: 33861372)
21. Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer.
Kontos S; Papatsoris A; Kominea A; Melachrinou M; Tanoglidi A; Kachrilas S; Karavitakis M; Balampani E; Sotiropoulou-Bonikou G
Urol Int; 2011; 87(2):151-8. PubMed ID: 21525722
[TBL] [Abstract][Full Text] [Related]
22. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
23. Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner.
Yoo JY; Choi HK; Choi KC; Park SY; Ota I; Yook JI; Lee YH; Kim K; Yoon HG
Mol Biol Cell; 2012 Aug; 23(15):2943-54. PubMed ID: 22675025
[TBL] [Abstract][Full Text] [Related]
24. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
[TBL] [Abstract][Full Text] [Related]
25. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
26. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
27. HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.
Groves IJ; Knight EL; Ang QY; Scarpini CG; Coleman N
Oncogene; 2016 Sep; 35(36):4773-86. PubMed ID: 26876196
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
29. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
[TBL] [Abstract][Full Text] [Related]
30. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
31. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
Hoppe-Seyler F; Butz K
J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
[TBL] [Abstract][Full Text] [Related]
32. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
33. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
[TBL] [Abstract][Full Text] [Related]
34. The nuclear receptor corepressor has organizational effects within the developing amygdala on juvenile social play and anxiety-like behavior.
Jessen HM; Kolodkin MH; Bychowski ME; Auger CJ; Auger AP
Endocrinology; 2010 Mar; 151(3):1212-20. PubMed ID: 20051490
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
Das S; Somasundaram K
Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
[TBL] [Abstract][Full Text] [Related]
36. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
[TBL] [Abstract][Full Text] [Related]
37. Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion.
Yang X; Lu L
Drug Res (Stuttg); 2015 Feb; 65(2):70-3. PubMed ID: 24831244
[TBL] [Abstract][Full Text] [Related]
38. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
39. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]